The Egyptian Journal of Neurology, Psychiatry and Neurosurgery (Feb 2019)

Prevalence of migraine in Upper Egypt

  • Hamdy N. El-Tallawy,
  • Wafaa M. Farghaly,
  • Mohamed A. Abdelhamed,
  • Reda Badry,
  • Tarek A. Rageh,
  • Wael T. Soliman,
  • Khaled O. Abdulghani,
  • Mahmoud Hassan,
  • Sayed Sobhy,
  • Ghaydaa A. Shehata

DOI
https://doi.org/10.1186/s41983-019-0067-x
Journal volume & issue
Vol. 55, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Migraine is a significant health problem due its frequency and accompanying morbidity. Objectives This study aims to estimate the prevalence of migraine headache among the population of Al-Quseir city (Upper Egypt) and its impact on the patients’ life. Methods This study is part of a door-to-door survey of major neurological disorders in Al-Quseir city, Red Sea Governorate. All inhabitants (n = 33,285 persons) were screened through door to door by three specialists of neurology. Then, positive cases were subjected to clinical and neurological examination by three staff members of neurology each separately. Respondents were identified as suffering from migraine with aura, migraine without aura, and probable migraine as defined by the diagnostic criteria of the International Headache Society (IHS). Migraine Disability Assessment Scale (MIDAS) questionnaire was used to assess the impact of the disease on the patients’ daily life. Results We identified 911 patients suffering from migraine. The lifetime prevalence was 3.38/100 with male prevalence of 1.95/100 and female prevalence of 4.8/100. The highest prevalence figures were found during early adult life (18–40 years) among both genders reaching a total prevalence of 4.77/100 (2.89/100 for male and 6.53/100 for female). Among migraine patients, most of the attacks recorded were of moderate to severe intensity (97%) although virtually 66% of migraine patients reported that headache significantly interfered with their daily activities. Conclusion Lifetime prevalence of migraine is 3.38/100. Migraine headache has a deleterious impact on the patient’s functional and wellbeing.

Keywords